Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide-Reference-Cited by-同舟云学术

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

Published:2008-09 Issue:9 Volume:14 Page:993-1003
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bredeson Christopher N.,Zhang Mei-Jie,Agovi Manza-A.,Bacigalupo Andrea,Bahlis Nizar J.,Ballen Karen,Brown Christopher,Chaudhry M. Ahsan,Horowitz Mary M.,Kurian Seira,Quinlan Diana,Muehlenbien Catherine E.,Russell James A.,Savoie Lynn,Rizzo J. Douglas,Stewart Douglas A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies;Khouri;J Clin Oncol,1998

2. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998

3. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia;Tauro;J Clin Oncol,2005

4. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning;Baron;J Clin Oncol,2005

5. Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives;Sandmaier;Biol Blood Marrow Transplant,2007

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial;Blood Cancer Journal;2024-08-21

2. Busulfan-Fludarabine Versus Busulfan-Cyclophosphamide for Allogeneic Transplant in Acute Myeloid Leukemia: Long Term Analysis of GITMO AML-R2 Trial;2024-07-18

3. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

4. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin;Bone Marrow Transplantation;2021-11-05

5. Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors;Bone Marrow Transplantation;2021-05-07